227 related articles for article (PubMed ID: 34907071)
1. Impact of carbapenem resistance on mortality in patients infected with
Zhou R; Fang X; Zhang J; Zheng X; Shangguan S; Chen S; Shen Y; Liu Z; Li J; Zhang R; Shen J; Walsh TR; Wang Y
BMJ Open; 2021 Dec; 11(12):e054971. PubMed ID: 34907071
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis.
Soontaros S; Leelakanok N
Am J Infect Control; 2019 Oct; 47(10):1200-1212. PubMed ID: 31072673
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.
van Loon K; Voor In 't Holt AF; Vos MC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038269
[TBL] [Abstract][Full Text] [Related]
5. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Stewardson AJ; Marimuthu K; Sengupta S; Allignol A; El-Bouseary M; Carvalho MJ; Hassan B; Delgado-Ramirez MA; Arora A; Bagga R; Owusu-Ofori AK; Ovosi JO; Aliyu S; Saad H; Kanj SS; Khanal B; Bhattarai B; Saha SK; Uddin J; Barman P; Sharma L; El-Banna T; Zahra R; Saleemi MA; Kaur A; Iregbu K; Uwaezuoke NS; Abi Hanna P; Feghali R; Correa AL; Munera MI; Le TAT; Tran TTN; Phukan C; Phukan C; Valderrama-Beltrán SL; Alvarez-Moreno C; Walsh TR; Harbarth S
Lancet Infect Dis; 2019 Jun; 19(6):601-610. PubMed ID: 31047852
[TBL] [Abstract][Full Text] [Related]
6. A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant
Saito S; Hayakawa K; Tsuzuki S; Ishikane M; Nagashima M; Mezaki K; Sugiki Y; Tajima T; Matsunaga N; Ide S; Kinoshita N; Kusama Y; Fujitomo Y; Nakamoto T; Toda Y; Kaku M; Kodama EN; Ohmagari N
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33257451
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis.
Ni W; Cai X; Wei C; Di X; Cui J; Wang R; Liu Y
Braz J Infect Dis; 2015; 19(2):170-80. PubMed ID: 25636193
[TBL] [Abstract][Full Text] [Related]
8. Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis.
Budhram DR; Mac S; Bielecki JM; Patel SN; Sander B
Infect Control Hosp Epidemiol; 2020 Jan; 41(1):37-43. PubMed ID: 31637986
[TBL] [Abstract][Full Text] [Related]
9. Frequency of and risk factors for carbapenem-resistant
Barber KE; Wagner JL; Larry RC; Stover KR
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
[No Abstract] [Full Text] [Related]
10. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
White BP; Patel S; Tsui J; Chastain DB
Infect Dis (Lond); 2019 Mar; 51(3):161-167. PubMed ID: 30663923
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
Son SK; Lee NR; Ko JH; Choi JK; Moon SY; Joo EJ; Peck KR; Park DA
J Antimicrob Chemother; 2018 Oct; 73(10):2631-2642. PubMed ID: 29800480
[TBL] [Abstract][Full Text] [Related]
12. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant
Cancelli F; Oliva A; De Angelis M; Mascellino MT; Mastroianni CM; Vullo V
Biomed Res Int; 2018; 2018():2785696. PubMed ID: 30581848
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
14. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.
Falagas ME; Tansarli GS; Karageorgopoulos DE; Vardakas KZ
Emerg Infect Dis; 2014 Jul; 20(7):1170-5. PubMed ID: 24959688
[TBL] [Abstract][Full Text] [Related]
15. Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review.
Zhang H; Liang B; Wang J; Cai Y
Int J Antimicrob Agents; 2021 Oct; 58(4):106410. PubMed ID: 34339776
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
17. EUropean prospective cohort study on
Gutiérrez-Gutiérrez B; Sojo-Dorado J; Bravo-Ferrer J; Cuperus N; de Kraker M; Kostyanev T; Raka L; Daikos G; Feifel J; Folgori L; Pascual A; Goossens H; O'Brien S; Bonten MJ; Rodríguez-Baño J;
BMJ Open; 2017 Apr; 7(4):e015365. PubMed ID: 28373258
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
Livorsi DJ; Chorazy ML; Schweizer ML; Balkenende EC; Blevins AE; Nair R; Samore MH; Nelson RE; Khader K; Perencevich EN
Antimicrob Resist Infect Control; 2018; 7():55. PubMed ID: 29719718
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ceftazidime-avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis.
Yang P; Li Y; Wang X; Chen N; Lu X
BMJ Open; 2023 May; 13(5):e070491. PubMed ID: 37137556
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis.
Alemayehu E; Fiseha T; Gedefie A; Alemayehu Tesfaye N; Ebrahim H; Ebrahim E; Fiseha M; Bisetegn H; Mohammed O; Tilahun M; Gebretsadik D; Debash H; Gobezie MY
BMC Infect Dis; 2023 May; 23(1):277. PubMed ID: 37138285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
